For more than six decades, metformin has served as the cornerstone of pharmacological intervention for type 2 diabetes, a condition…
Read More

For more than six decades, metformin has served as the cornerstone of pharmacological intervention for type 2 diabetes, a condition…
Read More
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More